GlobalData on MSN2d
Bavarian Nordic shares sink by 12% after mpox sales slump in Q3Bavarian Nordic has already secured a sizeable portion of revenue for 2025 through orders for its mpox/smallpox vaccine, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback